Kilitch Drugs India Ltd (KILITCH) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Kilitch Drugs India Ltd reported sales of ₹44.88 Cr, operating profit of ₹2.94 Cr (OPM 6.55%) and net profit of ₹1.96 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
KILITCH quarterly results (₹ Cr) Metric Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sales 47.47 56.17 61.23 43.14 48.92 53.81 89.6 44.88 Expenses 41.37 47.44 46.64 39.88 43.88 47.66 67.46 41.94 Operating Profit 6.1 8.73 14.59 3.26 5.04 6.15 22.14 2.94 OPM 12.85% 15.54% 23.83% 7.56% 10.3% 11.43% 24.71% 6.55% Other Income 5.16 1.73 1.7 2.56 6.66 1.53 0.49 2.9 Interest 0.31 1.4 1.6 1.53 1.44 1.15 1.44 0.88 Depreciation 0.61 0.81 0.85 0.84 0.86 0.94 0.98 1.09 Profit before tax 10.34 8.25 13.84 3.45 9.4 5.59 20.21 3.87 Tax 16.73% 32% 26.23% 34.49% 14.47% 22.9% 26.37% 48.84% Net Profit 8.61 5.61 10.22 2.27 8.04 4.31 14.88 1.96 EPS in Rs 2.46 1.7 2.97 0.87 2.34 1.27 4.15 0.83
KILITCH profit & loss, annual (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM Sales 114 140 154 198 235 237 Expenses 104 122 130 167 198 201 Operating Profit 10 18 24 32 37 36 OPM 9% 13% 16% 16% 16% 15% Other Income 3 3 4 11 11 12 Interest 1 5 6 5 6 5 Depreciation 2 4 3 3 4 4 Profit before tax 10 12 19 34 39 39 Tax 35% 31% 30% 28% 24% - Net Profit 6 8 14 25 30 29 EPS in Rs 2.17 3.08 4.17 7.63 8.63 8.59 Dividend Payout 0% 0% 0% 0% 0% -
KILITCH balance sheet (₹ Cr) Metric Mar 2023 Mar 2024 Mar 2025 Sep 2025 Mar 2026 Equity Capital 16 16 16 17 35 Reserves 136 160 186 248 245 Borrowings 22 32 49 84 89 Other Liabilities 46 32 61 49 89 Total Liabilities 220 240 313 399 458 Fixed Assets 64 62 64 64 67 CWIP 4 6 47 98 140 Investments 62 72 72 77 75 Other Assets 90 100 129 160 176 Total Assets 220 240 313 399 458
KILITCH cash flows (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity 6 3 -2 18 24 Cash from Investing Activity -15 8 -8 -40 -100 Cash from Financing Activity 7 -1 9 13 82 Net Cash Flow -2 10 -1 -9 6 Free Cash Flow -2 -1 -8 -29 -76 CFO/OP 79% 39% 23% 82% 92%
KILITCH ratios Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Debtor Days 132 142 149 156 186 Inventory Days 28 10 18 53 33 Days Payable 239 200 118 189 230 Cash Conversion Cycle -79 -48 50 20 -11 Working Capital Days -40 -4 30 56 49 ROCE 6% 10% 13% 16% 13%